MVEIX | VMVAX | MVEIX / VMVAX | |
Total Expense Ratio | 1.47 | 0.07 | 2,100% |
Annual Report Gross Expense Ratio | 1.47 | 0.07 | 2,100% |
Fund Existence | 27 years | 14 years | - |
Gain YTD | 2.062 | -0.023 | -9,101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 3000 | 333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.4M | 29.9B | 0% |
Annual Yield % from dividends | 0.96 | 2.31 | 41% |
Returns for 1 year | -3.05 | 7.23 | -42% |
Returns for 3 years | 14.41 | 24.99 | 58% |
Returns for 5 years | 14.86 | 69.23 | 21% |
Returns for 10 years | -34.79 | 78.81 | -44% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QRSAX | 40.15 | N/A | N/A |
FPA Queens Road Small Cap Value Advisor | |||
MGIBX | 38.88 | -0.43 | -1.09% |
MFS International Intrinsic Value B | |||
ZVGNX | 52.13 | -0.62 | -1.18% |
Zevenbergen Genea Investor | |||
VRMCX | 59.50 | -0.99 | -1.64% |
Virtus KAR Mid-Cap Core R6 | |||
BRSBX | 12.99 | -0.28 | -2.11% |
MFS Blended Research Small Cap Eq B |